FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317797029> ?p ?o ?g. }

• W4317797029 abstract "Acute exposure to high dose radiation can cause acute radiation syndrome (ARS), a potentially life-threatening illness. Individuals that survive ARS are at risk of developing the delayed effects of acute radiation exposure, with the lungs being particularly susceptible (DEARE-lung). For individuals at risk of radiation exposure, there are no Food and Drug Administration-approved medical countermeasures (MCMs) for prophylactic or post-exposure use that can prevent or mitigate DEARE-lung. BIO 300 is a novel formulation of synthetic genistein that has been extensively studied as a prophylactic MCM for the hematopoietic subsyndrome of ARS (H-ARS). Here, we used a C57L/J mouse model of total-body irradiation (TBI) to investigate whether prophylactic administration of BIO 300 is able to prevent animals from developing DEARE-lung. Oral and parenteral formulations of BIO 300 administered prior to TBI were compared against standard of care, PEGfilgrastim, administered shortly after radiation exposure, and the combination of oral BIO 300 administered prior to TBI and with PEGfilgrastim administered post-exposure. All animals were exposed to 7.75 Gy cobalt-60 gamma-radiation and the primary endpoint was lung histopathology at 180 days post-TBI. Animals treated with BIO 300 had a significant reduction in the incidence of interstitial lung inflammation compared to vehicle groups for both the oral (0% vs. 47%) and parenteral (13% vs. 44%) routes of administration. Similar results were obtained for the incidence and severity of pulmonary fibrosis in animals treated with oral BIO 300 (incidence, 47% vs. 100% and mean severity score, 0.53 vs. 1.3) and parenteral BIO 300 (incidence, 63% vs. 100% and mean severity score, 0.69 vs. 1.7). PEGfilgrastim alone had no significant effect in reducing the incidence of inflammation or fibrosis compared to vehicle. The combination of oral BIO 300 and PEGfilgrastim significantly reduced the incidence of interstitial inflammation (13% vs. 46%) and the severity of pulmonary fibrosis (mean severity score, 0.93 vs. 1.6). Results in the C57L/J mice were compared to those in CD2F1 mice, which are less prone to lung injury following total-body irradiation. Taken together, these studies indicate that BIO 300 is a promising MCM that is able to prophylactically protect against DEARE-lung." @default.
• W4317797029 created "2023-01-24" @default.
• W4317797029 creator A5000322586 @default.
• W4317797029 creator A5002407393 @default.
• W4317797029 creator A5065940802 @default.
• W4317797029 creator A5068527269 @default.
• W4317797029 creator A5085756151 @default.
• W4317797029 creator A5085922347 @default.
• W4317797029 creator A5091033126 @default.
• W4317797029 date "2023-01-23" @default.
• W4317797029 modified "2023-10-06" @default.
• W4317797029 title "The Radioprotectant, BIO 300, Protects the Lungs from Total-Body Irradiation Injury in C57L/J Mice" @default.
• W4317797029 cites W1920918690 @default.
• W4317797029 cites W1957311725 @default.
• W4317797029 cites W2006228102 @default.
• W4317797029 cites W2030819118 @default.
• W4317797029 cites W2032897155 @default.
• W4317797029 cites W2051840532 @default.
• W4317797029 cites W2071137965 @default.
• W4317797029 cites W2080416210 @default.
• W4317797029 cites W2100379694 @default.
• W4317797029 cites W2131546972 @default.
• W4317797029 cites W2139728410 @default.
• W4317797029 cites W2166205211 @default.
• W4317797029 cites W2523649561 @default.
• W4317797029 cites W2588511858 @default.
• W4317797029 cites W2759497087 @default.
• W4317797029 cites W2909343909 @default.
• W4317797029 cites W2943764774 @default.
• W4317797029 cites W3030189110 @default.
• W4317797029 cites W3194663062 @default.
• W4317797029 cites W3199878444 @default.
• W4317797029 cites W3206564738 @default.
• W4317797029 cites W4228999857 @default.
• W4317797029 cites W4285495454 @default.
• W4317797029 doi "https://doi.org/10.1667/rade-22-00142.1" @default.
• W4317797029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36689635" @default.
• W4317797029 hasPublicationYear "2023" @default.
• W4317797029 type Work @default.
• W4317797029 citedByCount "3" @default.
• W4317797029 countsByYear W43177970292023 @default.
• W4317797029 crossrefType "journal-article" @default.
• W4317797029 hasAuthorship W4317797029A5000322586 @default.
• W4317797029 hasAuthorship W4317797029A5002407393 @default.
• W4317797029 hasAuthorship W4317797029A5065940802 @default.
• W4317797029 hasAuthorship W4317797029A5068527269 @default.
• W4317797029 hasAuthorship W4317797029A5085756151 @default.
• W4317797029 hasAuthorship W4317797029A5085922347 @default.
• W4317797029 hasAuthorship W4317797029A5091033126 @default.
• W4317797029 hasBestOaLocation W43177970291 @default.
• W4317797029 hasConcept C109159458 @default.
• W4317797029 hasConcept C120665830 @default.
• W4317797029 hasConcept C121332964 @default.
• W4317797029 hasConcept C126322002 @default.
• W4317797029 hasConcept C2776694085 @default.
• W4317797029 hasConcept C2776755627 @default.
• W4317797029 hasConcept C2777714996 @default.
• W4317797029 hasConcept C2778880498 @default.
• W4317797029 hasConcept C28328180 @default.
• W4317797029 hasConcept C2908890008 @default.
• W4317797029 hasConcept C54355233 @default.
• W4317797029 hasConcept C61511704 @default.
• W4317797029 hasConcept C71924100 @default.
• W4317797029 hasConcept C86803240 @default.
• W4317797029 hasConcept C90924648 @default.
• W4317797029 hasConceptScore W4317797029C109159458 @default.
• W4317797029 hasConceptScore W4317797029C120665830 @default.
• W4317797029 hasConceptScore W4317797029C121332964 @default.
• W4317797029 hasConceptScore W4317797029C126322002 @default.
• W4317797029 hasConceptScore W4317797029C2776694085 @default.
• W4317797029 hasConceptScore W4317797029C2776755627 @default.
• W4317797029 hasConceptScore W4317797029C2777714996 @default.
• W4317797029 hasConceptScore W4317797029C2778880498 @default.
• W4317797029 hasConceptScore W4317797029C28328180 @default.
• W4317797029 hasConceptScore W4317797029C2908890008 @default.
• W4317797029 hasConceptScore W4317797029C54355233 @default.
• W4317797029 hasConceptScore W4317797029C61511704 @default.
• W4317797029 hasConceptScore W4317797029C71924100 @default.
• W4317797029 hasConceptScore W4317797029C86803240 @default.
• W4317797029 hasConceptScore W4317797029C90924648 @default.
• W4317797029 hasIssue "3" @default.
• W4317797029 hasLocation W43177970291 @default.
• W4317797029 hasLocation W43177970292 @default.
• W4317797029 hasOpenAccess W4317797029 @default.
• W4317797029 hasPrimaryLocation W43177970291 @default.
• W4317797029 hasRelatedWork W1580426574 @default.
• W4317797029 hasRelatedWork W1984877488 @default.
• W4317797029 hasRelatedWork W2089620537 @default.
• W4317797029 hasRelatedWork W2275480158 @default.
• W4317797029 hasRelatedWork W2323950372 @default.
• W4317797029 hasRelatedWork W2371214482 @default.
• W4317797029 hasRelatedWork W2407004706 @default.
• W4317797029 hasRelatedWork W2929987155 @default.
• W4317797029 hasRelatedWork W3095306390 @default.
• W4317797029 hasRelatedWork W4238089809 @default.
• W4317797029 hasVolume "199" @default.
• W4317797029 isParatext "false" @default.
• W4317797029 isRetracted "false" @default.
• W4317797029 workType "article" @default.